Intramuscular electroporation delivery of IFN-α gene therapy for inhibition of tumor growth located at a distant site

Gene Therapy

Volumn 8, Issue 5, 2001, Pages 400-407

  Li, S ^a   Zhang, X ^a   Xia, X ^a   Zhou, L ^a   Breau, R ^a   Suen, J ^a   Hanna, E ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Antiangiogenesis; Electroporation; Gene therapy; IFN ; IL 12; Muscle

Indexed keywords

ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; ENDOSTATIN; INTERLEUKIN 2; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ELECTROPORATION; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; IMMUNOCOMPETENCE; MOUSE; MOUSE STRAIN; MUSCLE TISSUE; NONHUMAN; PRIORITY JOURNAL; SERUM; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TUMOR LOCALIZATION; TUMOR VASCULARIZATION;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CHEMOKINES, CXC; ELECTROPORATION; FEMALE; GENE EXPRESSION; GENE THERAPY; GENES, REPORTER; INJECTIONS, INTRAMUSCULAR; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON-ALPHA; INTERLEUKIN-12; INTERLEUKIN-2; MICE; MICE, INBRED C3H; NEOVASCULARIZATION, PATHOLOGIC; SURVIVAL RATE;

ANIMALIA; MURINAE;

EID: 0035077793     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301418     Document Type: Article

References (41)

1. Enhancement of 5-fluorouracil cytotoxicity on human colon cancer cells by retrovirus-mediated interferon-alpha gene transfer
2. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons
3. Intralesional interferon alfa-2b in the treatment of basal cell carcinoma: Immunohistochemical study on cellular immune reaction leading to tumor regresion
4. Cytokine therapeutics: Lessons from interferon-α
5. Implantation of genetically manipulated fibroblasts into mice as antitumor α-interferon therapy
6. Human renal carcinoma line transfected with interleukin and/or interferon-α gene(s): Implication for live cancer vaccines
7. Interferon alpha-1 gene transfer into metastatic friend leukemia cells abrogated tumorigenicity in immunocompetent mice: Antitumor therapy by means of interferon-producing cells
8. Gene therapy with an adeno-associated virus carrying an interferon gene results in tumor growth suppression and egression
9. IFN-alpha-expression tumor cells enhance generation and promoter survival of tumor-specific CTLs
10. Nonviral interferon-alpha gene therapy inhibits growth of established tumors by eliciting a systemic immune response
11. Liposome-mediated gene transfer into human basal cell carcinoma
12. In vivo tumor suppression by adenovirus-mediated interferon alpha-2b gene delivery
13. Direct gene transfer into mouse muscle in vivo
14. A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon-α
15. Electropermeabilization of skeletal muscle enhances gene transfer in vivo
16. Gene transfer into muscle by electroporation in vivo
17. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation
18. Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. II. Role of host mechanisms
19. Antitumor effects of interferon
20. Interferons α and β downregulate the expression of basic fibroblast growth factor in human carcinomas
21. Interferon-α gene therapy for cancer: Retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models
22. Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule
23. The CXC chemokines IP-10 and Mig are necessary for IL-12 mediated regression of the mouse RENCA tumor
24. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo
25. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis
26. Tumor cell responses to IFN-gamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis
27. Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography
28. Hyaluronan fragments synergize with interferon-gamma to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages
29. Plasmid gene delivery: Advantages and limitations
30. Increased level and duration of expression in muscle by co-expression of a transactivator using plasmid systems
31. Enhancer and promoter chimeras in plasmids designed for intramuscular injection: A comparative in vivo and in vitro study
32. Protective interactive noncondensing (PINC) polymers for enhanced plasmid distribution and expression in rat skeletal muscle
33. In vivo gene electroinjection and expression in rat liver
34. High-efficiency in vivo gene transfer using intrarterial plasmid DNA injection following in vivo electroporation
35. High-efficiency gene transfer into skeletal muscle mediated by electric pulses
36. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
37. Intratracheal administration of interleukin 12 plasmid-cationic lipid complexes inhibits murine lung metastases
38. Antitumor activity of interleukin-1-alpha and cisplatin in a murine model system
39. A new immunocompetent murine model for oral cancer
40. Inhibition of growth of a murine squamous cell carcinoma by a cyclooxygenase inhibitior increases leukotriene B4 production
41. A translation-like and nuclear-associated mechanism dictate the nonsense codon-mediated TCR mature transcript decay